Before revision: Friedman served as CEO until the company was acquired by Abbott Laboratories in 2009 for 123 million; at that time the company had 160 employees and most of its operations and sales were in the US, the UK, and Hong Kong.
After revision: Friedman was CEO until the company was acquired by Abbott Laboratories in 2009 for 123 million; at that time the company had 160 employees and most of its operations and sales were in the US, the UK, and Hong Kong.